OptMed(OMED)

0.8900 0.0000 0.0%

今开：0.0昨收：0.89
最高：0.0 最低：0.0
涨停价：0.0跌停价：0.0
总市值：3.4434179E7

OptMed的最新讨论

从VEGF/DLL4双抗“三兄弟”的前世今生，分析双抗研发策略

同写意2022-05-14 21:40

撰文丨顾津明，同润生物CSO
编辑丨于靖
近日，Compass Therapeutics公布了其VEGF/DLL4（CTX-009）双特异抗体联合紫杉醇在治疗胆道癌（BTC）的2期临床中期研究成果，结果表明该双抗药物安全性良好，在24名患者中有10位病人平均治疗6个月后得到了客观缓解，ORR为42%（10/24），算不上惊艳，...查看全文

Horned_Reaper2019-04-23 19:41

$Oncomed制药(OMED)$ [鼓鼓掌][献花花]查看全文

Horned_Reaper2019-03-09 00:21

$Oncomed制药(OMED)$ 0.848加点仓，希望可以像SEEL一样起飞查看全文

Horned_Reaper2019-02-28 05:25

$Oncomed制药(OMED)$ 看来要再洗掉几层皮！航班开始无限期延误...[好困惑]查看全文

Horned_Reaper2019-02-21 05:51

$Oncomed制药(OMED)$ 看来飞机超载，要洗一洗才能起飞[滴汗]查看全文

Horned_Reaper2019-02-16 02:56

$Oncomed制药(OMED)$ 晚了一点起飞[加油]查看全文

Horned_Reaper2019-01-07 22:55

$Oncomed制药(OMED)$ 请收起小桌板，调直座椅靠背，系好安全带！查看全文

Horned_Reaper2019-01-04 23:35

$Oncomed制药(OMED)$ 随时要起飞的节奏…查看全文

有为的股价小宝石2018-12-27 00:15

$Oncomed制药(OMED)$ 要开涨了啊查看全文

usbiostock2018-08-03 09:49

$OncoMed Pharmaceuticals, Inc. (OMED)$ 1. Navicixizumab单药治疗实体瘤临床1a期试验一线数据预计：2018年第4季度；2. Etigilimab单药治疗进展性/转移性实体瘤临床1a期试验一线数据预计：2018年第4季度；3. 现金：$79.9M。查看全文

1 2 3

OptMed的公告

$ONCOMED PHARMACEUTICALS INC(OMED)$ EFFECT - Notice of Effectiveness Filed: 2015-07-22 AccNo: 9999999995-15-002019 Size: 1 KB 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ CT ORDER - Confidential treatment order Filed: 2015-07-16 AccNo: 9999999997-15-011926 Size: 17 KB 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ CT ORDER - Confidential treatment order Filed: 2015-07-16 AccNo: 9999999997-15-011925 Size: 14 KB 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ CORRESP [Cover] - Correspondence Filed: 2015-07-20 AccNo: 0001193125-15-256973 Size: 7 KB 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ 8-K - Current report Filed: 2015-08-10 AccNo: 0001193125-15-284911 Size: 282 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ 8-K - Current report Filed: 2015-06-29 AccNo: 0001193125-15-238088 Size: 34 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 7...

$ONCOMED PHARMACEUTICALS INC(OMED)$ 8-K - Current report Filed: 2015-06-25 AccNo: 0001193125-15-235099 Size: 19 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-08-10 AccNo: 0001193125-15-284927 Size: 2 MB 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ 内部交易: 2015-09-30,Director,LASERSOHN JACK W ,买入,11210普通股, $16.01

$ONCOMED PHARMACEUTICALS INC(OMED)$ 内部交易: 2015-09-29,Director,LASERSOHN JACK W ,买入,3140普通股, $14.15

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36